Lawrence H. Einhorn, MD, came to Indiana University in 1973 and is the university’s senior cancer research investigator. Dr. Einhorn has received numerous awards of distinction, including the American Association of Cancer Research’s award (Richard and Hinda Rosenthal Award), which he received in 1983, and ASCO’s Karnofsky Memorial Award, which he was awarded in 1990. Dr. Einhorn has also received the 1983 Medal of Honor from the American Cancer Society and the 1992 Kettering Prize for Cancer Research. In 2001, Dr. Einhorn was elected into the American Philosophical Society, the oldest learned society in the United States, which promotes scholarly research in the sciences and humanities. He joined the ranks of previous members which include Albert Einstein, Thomas Jefferson, and Benjamin Franklin. Other awards he has received are the NCI Outstanding Investigator Grant, the Distinguished Clinician Award (Milken Foundation), Clinical Oncology Award (ACCC), Distinguished Alumnus Award from M.D. Anderson, Riley Distinguished Lecturer at Indiana University, Jacquiatt Award in Oncology from Paris, France, Teaching Excellence Award from Indiana University, Lieber Award for Teacher of the Year from Indiana University, Herman B. Wells Vision Award from IU Bloomington, Indiana, and Daniel Nathans Memorial Award – Van Andel Institute in Grand Rapids, Michigan. Dr. Einhorn was honored on August 19, 2009, with the ringing of the New York Stock Exchange Bell for the ASCO Cancer Foundation.

Several decades ago, the cure rate for metastatic testicular cancer was only 5%, and the cure rate for all testis cancer patients combined was only 50%. Over the past thirty years, a number of new treatments have been developed at Indiana University by Dr. Lawrence Einhorn and his researchteam. As a result of Dr. Einhorn’s work, the cure rates for young men diagnosed with metastatic testicular cancer is now 80% and the overall cure rate for all testis cancer patients is an astounding95%.

Indiana University School of Medicine

The Gladstein family has pledged $1.2 million to the Indiana University School of Medicine to fund research on the link between cancer and genetics. The gift enabled the IU School of Medicine to establish the Harry and Edith Gladstein Chair in Cancer Epidemiology and Genetics. It is named to honor the parents of Andy Gladstein. Income generated by investing the gift through the IU Foundation will fund basic research in the understanding and treatment of cancer. “We very much want to help not only cancer patients but those who are at risk for cancer,” said Andy Gladstein. “We want to help Indiana University’s wonderful doctors and scientists address the disease at a fundamental level in order to find new ways to treat, and perhaps even prevent, cancer. What a source of hope this will be for the millions of people who battle cancer and for the families who support them.” With this chair, and with the outstanding work already coming from our laboratories and clinics, the Indiana University School of Medicine is strongly positioned in the field of cancer genetics.

The mission of the annual Gladstein lecture is to highlight the dramatic advances made in the diagnosis and treatment of cancer by genomic science.

Selection CommitteeEric Meslin Jamie RenbargerGeorge Sledge David Flockhart

Harry and Edith Gladstein Professors

First Annual 2009Laura van’t Veer, PhD

“Molecular Profiles of Breast and Colorectal Cancer in Patient Management”

Second Annual 2010Thomas J. Hudson, MD

“Genome Variation and Cancer”

Third Annual 2011Lawrence H. Einhorn, MD

“Lance Armstrong and the Tour de Cancer”

Harry and Edith Gladstein

Harry Gladstein, a native of Sellersburg, Indiana, was born in 1910 and graduated from Indiana University in 1931 with a Bachelor of Science degree in business. As a student, he was a manager of the track team and a member of Alpha Kappa Psi business honorary, the Board of Aeons, and Sigma Alpha Mu fraternity.

Mr. Gladstein had a long and distinguished career in newspaper publishing. He worked as a circulation executive for papers including the Los Angeles Examiner, Chicago Herald Examiner, and Louisville Courier Journal and Times before joining the Washington Post, where he spent much of his career. He held the position of vice president and business manager at the Washington Post at the time of his retirement in 1971. Former Washington Post publisher Katherine Graham noted that his influence was still felt at the paper more than 25 years after his retirement.

Gladstein was a member of the board of the United Jewish Appeal, World Affairs Council, United Way of the Desert, the Desert Hospital Foundation and the Eisenhower Medical Center Foundation. He served on the Washington Board of Trade and was the recipient of a Bronze Star for his service in World War II.

Recalling Harry Gladstein, Coordinator of Indiana University’s Men’s and Women’s Track and Cross Country Sam Bell said: “Harry was a people person, and it was apparent that he knew everybody and everybody knew him. He had a wonderful sense of humor.” We are honored to be able to have this Chair in Cancer Genomics named after him.

Gladstein contributed generously to Indiana University throughout his life, including gifts to the School of Business and for the restoration of the Student Building. In 1993, he established a trust to provide for the IU Track and Field Scholarship Program and to supply discretionary funds for the president of Indiana University. Now his widow, Edith, and son, Andrew are continuing his tradition of generosity and commitment to supporting cancer research at Indiana University.

LAWRENCE H. EINHORN, MD

Third Annual Harry and Edith Gladstein

Visiting Professor

“Lance Armstrong & the Tour de Cancer”

11:00AM May 5, 2011Walther Auditorium